nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Connective tissue disorder—Capecitabine—kidney cancer	0.000748	0.000748	CcSEcCtD
Milnacipran—Vomiting—Everolimus—kidney cancer	0.000747	0.000747	CcSEcCtD
Milnacipran—Urethral disorder—Capecitabine—kidney cancer	0.000746	0.000746	CcSEcCtD
Milnacipran—Paraesthesia—Vincristine—kidney cancer	0.000745	0.000745	CcSEcCtD
Milnacipran—Agitation—Paclitaxel—kidney cancer	0.000742	0.000742	CcSEcCtD
Milnacipran—Rash—Everolimus—kidney cancer	0.00074	0.00074	CcSEcCtD
Milnacipran—Dermatitis—Everolimus—kidney cancer	0.00074	0.00074	CcSEcCtD
Milnacipran—Headache—Vinblastine—kidney cancer	0.000738	0.000738	CcSEcCtD
Milnacipran—Headache—Everolimus—kidney cancer	0.000736	0.000736	CcSEcCtD
Milnacipran—Hypotension—Gemcitabine—kidney cancer	0.000735	0.000735	CcSEcCtD
Milnacipran—Abdominal pain—Dactinomycin—kidney cancer	0.000734	0.000734	CcSEcCtD
Milnacipran—Body temperature increased—Dactinomycin—kidney cancer	0.000734	0.000734	CcSEcCtD
Milnacipran—Asthenia—Sorafenib—kidney cancer	0.000731	0.000731	CcSEcCtD
Milnacipran—Syncope—Paclitaxel—kidney cancer	0.000724	0.000724	CcSEcCtD
Milnacipran—Leukopenia—Paclitaxel—kidney cancer	0.000723	0.000723	CcSEcCtD
Milnacipran—Hypersensitivity—Sunitinib—kidney cancer	0.000723	0.000723	CcSEcCtD
Milnacipran—Decreased appetite—Vincristine—kidney cancer	0.000721	0.000721	CcSEcCtD
Milnacipran—Pruritus—Sorafenib—kidney cancer	0.000721	0.000721	CcSEcCtD
Milnacipran—Vomiting—Erlotinib—kidney cancer	0.00072	0.00072	CcSEcCtD
Milnacipran—Erythema multiforme—Capecitabine—kidney cancer	0.00072	0.00072	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Vincristine—kidney cancer	0.000716	0.000716	CcSEcCtD
Milnacipran—Fatigue—Vincristine—kidney cancer	0.000715	0.000715	CcSEcCtD
Milnacipran—Rash—Erlotinib—kidney cancer	0.000714	0.000714	CcSEcCtD
Milnacipran—Dermatitis—Erlotinib—kidney cancer	0.000714	0.000714	CcSEcCtD
Milnacipran—Palpitations—Paclitaxel—kidney cancer	0.000713	0.000713	CcSEcCtD
Milnacipran—Hyponatraemia—Doxorubicin—kidney cancer	0.000712	0.000712	CcSEcCtD
Milnacipran—Insomnia—Gemcitabine—kidney cancer	0.000712	0.000712	CcSEcCtD
Milnacipran—Eye disorder—Capecitabine—kidney cancer	0.000711	0.000711	CcSEcCtD
Milnacipran—Headache—Erlotinib—kidney cancer	0.00071	0.00071	CcSEcCtD
Milnacipran—Loss of consciousness—Paclitaxel—kidney cancer	0.00071	0.00071	CcSEcCtD
Milnacipran—Constipation—Vincristine—kidney cancer	0.000709	0.000709	CcSEcCtD
Milnacipran—Paraesthesia—Gemcitabine—kidney cancer	0.000707	0.000707	CcSEcCtD
Milnacipran—Flushing—Capecitabine—kidney cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Cardiac disorder—Capecitabine—kidney cancer	0.000706	0.000706	CcSEcCtD
Milnacipran—Asthenia—Sunitinib—kidney cancer	0.000704	0.000704	CcSEcCtD
Milnacipran—Dyspnoea—Gemcitabine—kidney cancer	0.000702	0.000702	CcSEcCtD
Milnacipran—Nausea—Vinblastine—kidney cancer	0.0007	0.0007	CcSEcCtD
Milnacipran—Somnolence—Gemcitabine—kidney cancer	0.0007	0.0007	CcSEcCtD
Milnacipran—Convulsion—Paclitaxel—kidney cancer	0.000699	0.000699	CcSEcCtD
Milnacipran—Migraine—Doxorubicin—kidney cancer	0.000698	0.000698	CcSEcCtD
Milnacipran—Nausea—Everolimus—kidney cancer	0.000697	0.000697	CcSEcCtD
Milnacipran—Diarrhoea—Sorafenib—kidney cancer	0.000697	0.000697	CcSEcCtD
Milnacipran—Hypertension—Paclitaxel—kidney cancer	0.000697	0.000697	CcSEcCtD
Milnacipran—Pruritus—Sunitinib—kidney cancer	0.000694	0.000694	CcSEcCtD
Milnacipran—Angiopathy—Capecitabine—kidney cancer	0.00069	0.00069	CcSEcCtD
Milnacipran—Chest pain—Paclitaxel—kidney cancer	0.000687	0.000687	CcSEcCtD
Milnacipran—Mediastinal disorder—Capecitabine—kidney cancer	0.000686	0.000686	CcSEcCtD
Milnacipran—Anxiety—Paclitaxel—kidney cancer	0.000685	0.000685	CcSEcCtD
Milnacipran—Decreased appetite—Gemcitabine—kidney cancer	0.000684	0.000684	CcSEcCtD
Milnacipran—Hypersensitivity—Dactinomycin—kidney cancer	0.000684	0.000684	CcSEcCtD
Milnacipran—Chills—Capecitabine—kidney cancer	0.000683	0.000683	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000683	0.000683	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000679	0.000679	CcSEcCtD
Milnacipran—Fatigue—Gemcitabine—kidney cancer	0.000678	0.000678	CcSEcCtD
Milnacipran—Gastrointestinal pain—Vincristine—kidney cancer	0.000678	0.000678	CcSEcCtD
Milnacipran—Dizziness—Sorafenib—kidney cancer	0.000674	0.000674	CcSEcCtD
Milnacipran—Constipation—Gemcitabine—kidney cancer	0.000673	0.000673	CcSEcCtD
Milnacipran—Nausea—Erlotinib—kidney cancer	0.000673	0.000673	CcSEcCtD
Milnacipran—Dry mouth—Paclitaxel—kidney cancer	0.000672	0.000672	CcSEcCtD
Milnacipran—Diarrhoea—Sunitinib—kidney cancer	0.000671	0.000671	CcSEcCtD
Milnacipran—Mental disorder—Capecitabine—kidney cancer	0.000667	0.000667	CcSEcCtD
Milnacipran—Asthenia—Dactinomycin—kidney cancer	0.000666	0.000666	CcSEcCtD
Milnacipran—Malnutrition—Capecitabine—kidney cancer	0.000663	0.000663	CcSEcCtD
Milnacipran—Abdominal pain—Vincristine—kidney cancer	0.000656	0.000656	CcSEcCtD
Milnacipran—Body temperature increased—Vincristine—kidney cancer	0.000656	0.000656	CcSEcCtD
Milnacipran—Liver function test abnormal—Doxorubicin—kidney cancer	0.000655	0.000655	CcSEcCtD
Milnacipran—Infection—Paclitaxel—kidney cancer	0.000655	0.000655	CcSEcCtD
Milnacipran—Flatulence—Capecitabine—kidney cancer	0.000653	0.000653	CcSEcCtD
Milnacipran—Dry skin—Doxorubicin—kidney cancer	0.00065	0.00065	CcSEcCtD
Milnacipran—Dysgeusia—Capecitabine—kidney cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Dizziness—Sunitinib—kidney cancer	0.000649	0.000649	CcSEcCtD
Milnacipran—Shock—Paclitaxel—kidney cancer	0.000648	0.000648	CcSEcCtD
Milnacipran—Vomiting—Sorafenib—kidney cancer	0.000648	0.000648	CcSEcCtD
Milnacipran—Nervous system disorder—Paclitaxel—kidney cancer	0.000646	0.000646	CcSEcCtD
Milnacipran—Thrombocytopenia—Paclitaxel—kidney cancer	0.000645	0.000645	CcSEcCtD
Milnacipran—Tachycardia—Paclitaxel—kidney cancer	0.000643	0.000643	CcSEcCtD
Milnacipran—Rash—Sorafenib—kidney cancer	0.000643	0.000643	CcSEcCtD
Milnacipran—Dermatitis—Sorafenib—kidney cancer	0.000642	0.000642	CcSEcCtD
Milnacipran—Breast disorder—Doxorubicin—kidney cancer	0.000641	0.000641	CcSEcCtD
Milnacipran—Skin disorder—Paclitaxel—kidney cancer	0.00064	0.00064	CcSEcCtD
Milnacipran—Headache—Sorafenib—kidney cancer	0.000639	0.000639	CcSEcCtD
Milnacipran—Hyperhidrosis—Paclitaxel—kidney cancer	0.000637	0.000637	CcSEcCtD
Milnacipran—Diarrhoea—Dactinomycin—kidney cancer	0.000635	0.000635	CcSEcCtD
Milnacipran—Anorexia—Paclitaxel—kidney cancer	0.000628	0.000628	CcSEcCtD
Milnacipran—Vision blurred—Capecitabine—kidney cancer	0.000624	0.000624	CcSEcCtD
Milnacipran—Vomiting—Sunitinib—kidney cancer	0.000624	0.000624	CcSEcCtD
Milnacipran—Body temperature increased—Gemcitabine—kidney cancer	0.000622	0.000622	CcSEcCtD
Milnacipran—Tremor—Capecitabine—kidney cancer	0.000621	0.000621	CcSEcCtD
Milnacipran—Rash—Sunitinib—kidney cancer	0.000618	0.000618	CcSEcCtD
Milnacipran—Dermatitis—Sunitinib—kidney cancer	0.000618	0.000618	CcSEcCtD
Milnacipran—Abdominal distension—Doxorubicin—kidney cancer	0.000617	0.000617	CcSEcCtD
Milnacipran—Hypotension—Paclitaxel—kidney cancer	0.000616	0.000616	CcSEcCtD
Milnacipran—Headache—Sunitinib—kidney cancer	0.000614	0.000614	CcSEcCtD
Milnacipran—Hypersensitivity—Vincristine—kidney cancer	0.000611	0.000611	CcSEcCtD
Milnacipran—Nausea—Sorafenib—kidney cancer	0.000605	0.000605	CcSEcCtD
Milnacipran—Angina pectoris—Doxorubicin—kidney cancer	0.000597	0.000597	CcSEcCtD
Milnacipran—Insomnia—Paclitaxel—kidney cancer	0.000596	0.000596	CcSEcCtD
Milnacipran—Asthenia—Vincristine—kidney cancer	0.000595	0.000595	CcSEcCtD
Milnacipran—Syncope—Capecitabine—kidney cancer	0.000594	0.000594	CcSEcCtD
Milnacipran—Leukopenia—Capecitabine—kidney cancer	0.000593	0.000593	CcSEcCtD
Milnacipran—Paraesthesia—Paclitaxel—kidney cancer	0.000592	0.000592	CcSEcCtD
Milnacipran—Vomiting—Dactinomycin—kidney cancer	0.00059	0.00059	CcSEcCtD
Milnacipran—Dyspnoea—Paclitaxel—kidney cancer	0.000587	0.000587	CcSEcCtD
Milnacipran—Somnolence—Paclitaxel—kidney cancer	0.000586	0.000586	CcSEcCtD
Milnacipran—Palpitations—Capecitabine—kidney cancer	0.000585	0.000585	CcSEcCtD
Milnacipran—Rash—Dactinomycin—kidney cancer	0.000585	0.000585	CcSEcCtD
Milnacipran—Nausea—Sunitinib—kidney cancer	0.000583	0.000583	CcSEcCtD
Milnacipran—Loss of consciousness—Capecitabine—kidney cancer	0.000582	0.000582	CcSEcCtD
Milnacipran—Dyspepsia—Paclitaxel—kidney cancer	0.00058	0.00058	CcSEcCtD
Milnacipran—Dysuria—Doxorubicin—kidney cancer	0.000573	0.000573	CcSEcCtD
Milnacipran—Neutropenia—Doxorubicin—kidney cancer	0.000573	0.000573	CcSEcCtD
Milnacipran—Decreased appetite—Paclitaxel—kidney cancer	0.000573	0.000573	CcSEcCtD
Milnacipran—Hypertension—Capecitabine—kidney cancer	0.000572	0.000572	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.00057	0.00057	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000569	0.000569	CcSEcCtD
Milnacipran—Fatigue—Paclitaxel—kidney cancer	0.000568	0.000568	CcSEcCtD
Milnacipran—Diarrhoea—Vincristine—kidney cancer	0.000568	0.000568	CcSEcCtD
Milnacipran—Pollakiuria—Doxorubicin—kidney cancer	0.000566	0.000566	CcSEcCtD
Milnacipran—Asthenia—Gemcitabine—kidney cancer	0.000565	0.000565	CcSEcCtD
Milnacipran—Chest pain—Capecitabine—kidney cancer	0.000564	0.000564	CcSEcCtD
Milnacipran—Constipation—Paclitaxel—kidney cancer	0.000563	0.000563	CcSEcCtD
Milnacipran—Anxiety—Capecitabine—kidney cancer	0.000562	0.000562	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00056	0.00056	CcSEcCtD
Milnacipran—Pruritus—Gemcitabine—kidney cancer	0.000557	0.000557	CcSEcCtD
Milnacipran—Weight decreased—Doxorubicin—kidney cancer	0.000555	0.000555	CcSEcCtD
Milnacipran—Dry mouth—Capecitabine—kidney cancer	0.000552	0.000552	CcSEcCtD
Milnacipran—Nausea—Dactinomycin—kidney cancer	0.000552	0.000552	CcSEcCtD
Milnacipran—Dizziness—Vincristine—kidney cancer	0.000549	0.000549	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000542	0.000542	CcSEcCtD
Milnacipran—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000539	0.000539	CcSEcCtD
Milnacipran—Diarrhoea—Gemcitabine—kidney cancer	0.000538	0.000538	CcSEcCtD
Milnacipran—Infection—Capecitabine—kidney cancer	0.000537	0.000537	CcSEcCtD
Milnacipran—Shock—Capecitabine—kidney cancer	0.000532	0.000532	CcSEcCtD
Milnacipran—Urinary tract infection—Doxorubicin—kidney cancer	0.000531	0.000531	CcSEcCtD
Milnacipran—Nervous system disorder—Capecitabine—kidney cancer	0.00053	0.00053	CcSEcCtD
Milnacipran—Thrombocytopenia—Capecitabine—kidney cancer	0.000529	0.000529	CcSEcCtD
Milnacipran—Tachycardia—Capecitabine—kidney cancer	0.000528	0.000528	CcSEcCtD
Milnacipran—Vomiting—Vincristine—kidney cancer	0.000527	0.000527	CcSEcCtD
Milnacipran—Skin disorder—Capecitabine—kidney cancer	0.000525	0.000525	CcSEcCtD
Milnacipran—Urticaria—Paclitaxel—kidney cancer	0.000523	0.000523	CcSEcCtD
Milnacipran—Rash—Vincristine—kidney cancer	0.000523	0.000523	CcSEcCtD
Milnacipran—Hyperhidrosis—Capecitabine—kidney cancer	0.000523	0.000523	CcSEcCtD
Milnacipran—Dermatitis—Vincristine—kidney cancer	0.000523	0.000523	CcSEcCtD
Milnacipran—Haematuria—Doxorubicin—kidney cancer	0.000521	0.000521	CcSEcCtD
Milnacipran—Abdominal pain—Paclitaxel—kidney cancer	0.000521	0.000521	CcSEcCtD
Milnacipran—Body temperature increased—Paclitaxel—kidney cancer	0.000521	0.000521	CcSEcCtD
Milnacipran—Headache—Vincristine—kidney cancer	0.00052	0.00052	CcSEcCtD
Milnacipran—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000517	0.000517	CcSEcCtD
Milnacipran—Anorexia—Capecitabine—kidney cancer	0.000515	0.000515	CcSEcCtD
Milnacipran—Hypotension—Capecitabine—kidney cancer	0.000505	0.000505	CcSEcCtD
Milnacipran—Vomiting—Gemcitabine—kidney cancer	0.0005	0.0005	CcSEcCtD
Milnacipran—Rash—Gemcitabine—kidney cancer	0.000496	0.000496	CcSEcCtD
Milnacipran—Dermatitis—Gemcitabine—kidney cancer	0.000496	0.000496	CcSEcCtD
Milnacipran—Headache—Gemcitabine—kidney cancer	0.000493	0.000493	CcSEcCtD
Milnacipran—Nausea—Vincristine—kidney cancer	0.000493	0.000493	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—kidney cancer	0.000491	0.000491	CcSEcCtD
Milnacipran—Insomnia—Capecitabine—kidney cancer	0.000489	0.000489	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—kidney cancer	0.000488	0.000488	CcSEcCtD
Milnacipran—Paraesthesia—Capecitabine—kidney cancer	0.000486	0.000486	CcSEcCtD
Milnacipran—Hypersensitivity—Paclitaxel—kidney cancer	0.000485	0.000485	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—kidney cancer	0.000484	0.000484	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—kidney cancer	0.000483	0.000483	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—kidney cancer	0.000482	0.000482	CcSEcCtD
Milnacipran—Dyspnoea—Capecitabine—kidney cancer	0.000482	0.000482	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—kidney cancer	0.000481	0.000481	CcSEcCtD
Milnacipran—Dyspepsia—Capecitabine—kidney cancer	0.000476	0.000476	CcSEcCtD
Milnacipran—Asthenia—Paclitaxel—kidney cancer	0.000473	0.000473	CcSEcCtD
Milnacipran—Decreased appetite—Capecitabine—kidney cancer	0.00047	0.00047	CcSEcCtD
Milnacipran—Nausea—Gemcitabine—kidney cancer	0.000467	0.000467	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000467	0.000467	CcSEcCtD
Milnacipran—Fatigue—Capecitabine—kidney cancer	0.000466	0.000466	CcSEcCtD
Milnacipran—Pruritus—Paclitaxel—kidney cancer	0.000466	0.000466	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—kidney cancer	0.000464	0.000464	CcSEcCtD
Milnacipran—Constipation—Capecitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—kidney cancer	0.000458	0.000458	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—kidney cancer	0.000455	0.000455	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—kidney cancer	0.000455	0.000455	CcSEcCtD
Milnacipran—Diarrhoea—Paclitaxel—kidney cancer	0.000451	0.000451	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—kidney cancer	0.000445	0.000445	CcSEcCtD
Milnacipran—Gastrointestinal pain—Capecitabine—kidney cancer	0.000442	0.000442	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—kidney cancer	0.000442	0.000442	CcSEcCtD
Milnacipran—Chills—Doxorubicin—kidney cancer	0.00044	0.00044	CcSEcCtD
Milnacipran—Dizziness—Paclitaxel—kidney cancer	0.000436	0.000436	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—kidney cancer	0.00043	0.00043	CcSEcCtD
Milnacipran—Urticaria—Capecitabine—kidney cancer	0.00043	0.00043	CcSEcCtD
Milnacipran—Body temperature increased—Capecitabine—kidney cancer	0.000427	0.000427	CcSEcCtD
Milnacipran—Abdominal pain—Capecitabine—kidney cancer	0.000427	0.000427	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—kidney cancer	0.000427	0.000427	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—kidney cancer	0.000421	0.000421	CcSEcCtD
Milnacipran—Tension—Doxorubicin—kidney cancer	0.000419	0.000419	CcSEcCtD
Milnacipran—Vomiting—Paclitaxel—kidney cancer	0.000419	0.000419	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—kidney cancer	0.000418	0.000418	CcSEcCtD
Milnacipran—Rash—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Milnacipran—Dermatitis—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Milnacipran—Headache—Paclitaxel—kidney cancer	0.000413	0.000413	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Milnacipran—Hypersensitivity—Capecitabine—kidney cancer	0.000398	0.000398	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—kidney cancer	0.000392	0.000392	CcSEcCtD
Milnacipran—Nausea—Paclitaxel—kidney cancer	0.000391	0.000391	CcSEcCtD
Milnacipran—Asthenia—Capecitabine—kidney cancer	0.000388	0.000388	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—kidney cancer	0.000383	0.000383	CcSEcCtD
Milnacipran—Pruritus—Capecitabine—kidney cancer	0.000383	0.000383	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—kidney cancer	0.000382	0.000382	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—kidney cancer	0.000377	0.000377	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—kidney cancer	0.000375	0.000375	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—kidney cancer	0.00037	0.00037	CcSEcCtD
Milnacipran—Diarrhoea—Capecitabine—kidney cancer	0.00037	0.00037	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—kidney cancer	0.000369	0.000369	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—kidney cancer	0.000364	0.000364	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—kidney cancer	0.000362	0.000362	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000361	0.000361	CcSEcCtD
Milnacipran—Dizziness—Capecitabine—kidney cancer	0.000358	0.000358	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—kidney cancer	0.000356	0.000356	CcSEcCtD
Milnacipran—Infection—Doxorubicin—kidney cancer	0.000346	0.000346	CcSEcCtD
Milnacipran—Vomiting—Capecitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Milnacipran—Shock—Doxorubicin—kidney cancer	0.000343	0.000343	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—kidney cancer	0.000342	0.000342	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—kidney cancer	0.000341	0.000341	CcSEcCtD
Milnacipran—Rash—Capecitabine—kidney cancer	0.000341	0.000341	CcSEcCtD
Milnacipran—Dermatitis—Capecitabine—kidney cancer	0.000341	0.000341	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—kidney cancer	0.00034	0.00034	CcSEcCtD
Milnacipran—Headache—Capecitabine—kidney cancer	0.000339	0.000339	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—kidney cancer	0.000339	0.000339	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—kidney cancer	0.000337	0.000337	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—kidney cancer	0.000332	0.000332	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—kidney cancer	0.000326	0.000326	CcSEcCtD
Milnacipran—Nausea—Capecitabine—kidney cancer	0.000321	0.000321	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—kidney cancer	0.000315	0.000315	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—kidney cancer	0.000313	0.000313	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—kidney cancer	0.000311	0.000311	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—kidney cancer	0.00031	0.00031	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—kidney cancer	0.000307	0.000307	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—kidney cancer	0.000303	0.000303	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000301	0.000301	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—kidney cancer	0.0003	0.0003	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000285	0.000285	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—kidney cancer	0.000277	0.000277	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—kidney cancer	0.000276	0.000276	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—kidney cancer	0.00025	0.00025	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—kidney cancer	0.000247	0.000247	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—kidney cancer	0.000238	0.000238	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—kidney cancer	0.00023	0.00023	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—kidney cancer	0.000222	0.000222	CcSEcCtD
Milnacipran—Rash—Doxorubicin—kidney cancer	0.00022	0.00022	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—kidney cancer	0.00022	0.00022	CcSEcCtD
Milnacipran—Headache—Doxorubicin—kidney cancer	0.000218	0.000218	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—kidney cancer	0.000207	0.000207	CcSEcCtD
